{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:03:45Z","timestamp":1778900625129,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates collected from community-acquired respiratory tract infections (CA-RTIs) in 2016\u201318 in four Asian countries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 260 S. pneumoniae and 258 H. influenzae isolates were tested. Pneumococci from Vietnam (n\u2009=\u2009161) were the least susceptible, with rates of susceptibility &amp;gt;90% for fluoroquinolones by CLSI breakpoints, \u223c60% for amoxicillin, amoxicillin\/clavulanic acid and ceftriaxone but &amp;lt;14% for most other agents. Pneumococcal isolates from Cambodia (n\u2009=\u200948) and Singapore (n\u2009=\u200934) showed susceptibilities ranging from \u223c30% for trimethoprim\/sulfamethoxazole and oral penicillin to 100% for fluoroquinolones. Among isolates of H. influenzae from Cambodia (n\u2009=\u200930), the Philippines (n\u2009=\u200959) and Singapore (n\u2009=\u200980), rates of susceptibility using CLSI breakpoints were &amp;gt;90% for amoxicillin\/clavulanic acid, cephalosporins [except cefaclor in Singapore (77.5%)], macrolides and fluoroquinolones; for isolates from Vietnam (n\u2009=\u200989) the rates of susceptibility were &amp;gt;85% only for amoxicillin\/clavulanic acid (95.5%), ceftriaxone (100%) and macrolides (87.6%\u201389.9%). Susceptibility to other antibiotics ranged from 7.9% (trimethoprim\/sulfamethoxazole) to 57.3%\u201359.6% (fluoroquinolones) and 70.8% (cefixime). The application of different EUCAST breakpoints for low and higher doses for some of the antibiotics (amoxicillin, amoxicillin\/clavulanic acid, ampicillin, penicillin, ceftriaxone, clarithromycin, erythromycin, levofloxacin and trimethoprim\/sulfamethoxazole) allowed, for the first time in a SOAR study, the effect of raising the dosage on susceptibility to be quantified. A limitation of the study was the small sample sizes and only one or two sites participating per country; however, since susceptibility data are scarce in some of the participating countries any information concerning antibiotic susceptibility is of value.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antibiotic susceptibility varied across countries and species, with isolates from Vietnam demonstrating the lowest susceptibility. Knowledge of resistance patterns can be helpful for clinicians when choosing empirical therapy options for CA-RTIs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa082","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T20:33:21Z","timestamp":1584390801000},"page":"i19-i42","source":"Crossref","is-referenced-by-count":14,"title":["Results from the Survey of Antibiotic Resistance (SOAR) 2016\u201318 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints"],"prefix":"10.1093","volume":"75","author":[{"given":"D","family":"Torumkuney","sequence":"first","affiliation":[{"name":"GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P H","family":"Van","sequence":"first","affiliation":[{"name":"Nguyen Tri Phuong Hospital, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Q","family":"Thinh","sequence":"first","affiliation":[{"name":"Children Hospital 1, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H","family":"Koo","sequence":"first","affiliation":[{"name":"Clinical Trials & Research Unit, Changi General Hospital, 2 Simei Street 3, 529889 Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, 2 Simei Street 3, 529889 Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P Q","family":"Lim","sequence":"first","affiliation":[{"name":"Clinical Trials & Research Unit, Changi General Hospital, 2 Simei Street 3, 529889 Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Sivhour","sequence":"first","affiliation":[{"name":"Battambang Provincial Referral Hospital Prek Mohatep Village, Svaypor Commune, Battambang City and Battambang Province, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Lamleav","sequence":"first","affiliation":[{"name":"Siem Reap Provincial Referral Hospital Mondul 1 Village, Svay Dangum Commune, Siem Reap City, Siem Reap Province, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Somary","sequence":"first","affiliation":[{"name":"Kampong Cham Provincial Referral Hospital, Praketmealea Road, #7 Village, Kampong Cham Commune, Kampong Cham City, Kampong Cham Province, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sosorphea","sequence":"first","affiliation":[{"name":"Takeo Provincial Referral Hospital, Phumi 3 Village, RokaKnong Commune, Daunkeo Town, Takeo Province, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Lagamayo","sequence":"first","affiliation":[{"name":"St. Luke\u2019s Medical Center Quezon City, Institute of Pathology, Microbiology Section, 279 E Rodriguez SR. BLVD Cathedral Heights, Quezon City, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Morrissey","sequence":"first","affiliation":[{"name":"IHMA Europe S\u00e0rl, Route de l\u2019Ile-au-Bois 1A, 1870 Monthey\/VS, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"2020042620061364600_dkaa082-B1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/s-0036-1592075","article-title":"Community-acquired pneumonia in the Asia-Pacific region","volume":"37","author":"Song","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"2020042620061364600_dkaa082-B2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2018.10.004","article-title":"Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America","volume":"77","author":"Sader","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2020042620061364600_dkaa082-B3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/ofid\/ofy263","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2020042620061364600_dkaa082-B4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020042620061364600_dkaa082-B5","doi-asserted-by":"crossref","first-page":"j2471","DOI":"10.1136\/bmj.j2471","article-title":"Advances in the causes and management of community-acquired pneumonia in adults","volume":"358","author":"Wunderink","year":"2017","journal-title":"BMJ"},{"key":"2020042620061364600_dkaa082-B6","year":"2018"},{"key":"2020042620061364600_dkaa082-B7","year":"2019"},{"key":"2020042620061364600_dkaa082-B8","year":"2019"},{"key":"2020042620061364600_dkaa082-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otohns.2003.12.003","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"130","author":"Anon","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2020042620061364600_dkaa082-B10","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042620061364600_dkaa082-B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12879-019-3861-2","article-title":"An alarmingly high nasal carriage rate of Streptococcus pneumoniae serotype 19F non-susceptible to multiple \u03b2-lactam antimicrobials among Vietnamese children","volume":"19","author":"Nguyen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2020042620061364600_dkaa082-B12","doi-asserted-by":"crossref","first-page":"i93","DOI":"10.1093\/jac\/dkw069","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2009\u201311 in Vietnam","volume":"71","author":"Van","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042620061364600_dkaa082-B13","doi-asserted-by":"crossref","first-page":"e89637","DOI":"10.1371\/journal.pone.0089637","article-title":"Etiologies and resistance profiles of bacterial community-acquired pneumonia in Cambodian and neighboring countries\u2019 health care settings: a systematic review (1995 to 2012)","volume":"9","author":"Goyet","year":"2014","journal-title":"PLoS One"},{"key":"2020042620061364600_dkaa082-B14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4269\/ajtmh.17-0692","article-title":"Serotype distribution of clinical Streptococcus pneumoniae isolates before the introduction of the 13-valent pneumococcal conjugate vaccine in Cambodia","volume":"98","author":"Inghammar","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020042620061364600_dkaa082-B15","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3201\/eid2111.150914","article-title":"Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia","volume":"21","author":"Turner","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020042620061364600_dkaa082-B16","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkw073","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2012\u201314 in Thailand, India, South Korea and Singapore","volume":"71","author":"Torumkuney","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042620061364600_dkaa082-B17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1440-1843.2011.02036.x","article-title":"Increasing antibiotic resistance in Streptococcus pneumoniae colonizing children attending day-care centres in Singapore","volume":"16","author":"Vasoo","year":"2011","journal-title":"Respirology"},{"key":"2020042620061364600_dkaa082-B18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40121-016-0112-3","article-title":"In vitro activity of oral antimicrobial agents against pathogens associated with community-acquired upper respiratory tract and urinary tract infections: a five country surveillance study","volume":"5","author":"Biedenbach","year":"2016","journal-title":"Infect Dis Ther"},{"key":"2020042620061364600_dkaa082-B19","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3201\/eid2008.140341","article-title":"Levofloxacin-resistant Haemophilus influenzae, Taiwan, 2004-2010","volume":"20","author":"Kuo","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2020042620061364600_dkaa082-B20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jmii.2016.04.002","article-title":"Increasing resistance to fluoroquinolones among Haemophilus species in Southern Taiwan","volume":"50","author":"Chang","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"2020042620061364600_dkaa082-B21","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc12705","article-title":"Meropenem and piperacillin\/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic\/pharmacodynamic target attainment when extended infusions are used?","volume":"17","author":"Carlier","year":"2013","journal-title":"Crit Care"},{"key":"2020042620061364600_dkaa082-B22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40262-018-0643-8","article-title":"Target-controlled continuous infusion for antibiotic dosing: proof-of-principle in an in-silico vancomycin trial in intensive care unit patients","volume":"57","author":"Colin","year":"2018","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/Supplement_1\/i19\/33121625\/dkaa082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/Supplement_1\/i19\/33121625\/dkaa082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:06:55Z","timestamp":1587946015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/Supplement_1\/i19\/5824466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":22,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,4,21]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa082","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4,1]]}}}